SCHEMBL3095935

SCHEMBL3095935

O=C(O)c1ccc2c(c1)CN(C(=O)C=Cc1ccccc1Cl)CC2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
TAAR1 Q96RJ0 1/20 0.50
HPGD P15428 4/20 0.47
HTT P42858 3/20 0.47
LMNA P02545 2/20 0.47
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
BCHE P06276 1/20 0.46
POLB P06746 1/20 0.46
F2R P25116 1/20 0.45
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
KDM4E B2RXH2 1/20 0.44
MAPK1 P28482 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
MYC P01106 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3095929 1.00 MAPT (0.54) MAPTL3MBTL1MEN1KMT2ATAAR1
SCHEMBL15062703 0.84 MAPT (0.51) MAPTL3MBTL1MEN1KMT2ATAAR1
SCHEMBL3288604 0.80 MAPT (0.49) MAPTMEN1KMT2ATAAR1HPGD
SCHEMBL3095946 0.78 HPGD (0.71) KMT2AHPGDHTTLMNANPC1
SCHEMBL3084013 0.78 BDKRB1 (0.51) MAPTL3MBTL1HPGDCYP1A2CYP2C9
SCHEMBL3084016 0.78 BDKRB1 (0.51) MAPTL3MBTL1HPGDCYP1A2CYP2C9
SCHEMBL4281897 0.76 MAPT (0.68) MAPTL3MBTL1MEN1KMT2ATAAR1
SCHEMBL4281905 0.76 MAPT (0.68) MAPTL3MBTL1MEN1KMT2ATAAR1
SCHEMBL12684545 0.76 HDAC6 (0.59) MAPTMEN1KMT2ATAAR1HPGD
SCHEMBL3089936 0.75 ERCC1 (0.54) KMT2AHPGDHTTLMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8357717-B2 Spiro group-containing amide compounds having bradykinin 1 receptor (B1R) activity GRUENENTHAL GMBH (DE) 2013-01-22 US disclosed
US-20100234340-A1 Substituted Spiroamide Compounds GRUENENTHAL GMBH (DE) 2010-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234340-A1 Substituted Spiroamide Compounds BDKRB1, BDKRB2, AVPR1B MAPT 3846/4885L3MBTL1 4344/4885MEN1 1130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.